Hanmi Pharm

Last updated • 3 min readFrom Wikipedia, The Free Encyclopedia
Hanmi Pharm Co., Ltd.
Native name
한미약품
Romanized name
Hanmiyagpum
Industry Pharmaceutical
Founded1973;51 years ago (1973)
FounderLim Sung-ki
Headquarters,
South Korea
Website hanmi.co.kr
  1. 1 2 Ji-young, Sohn (17 October 2016). "Hanmi Pharmaceutical raided over alleged info leak". The Korea Herald .
  2. 1 2 Dong-chan, Jhoo (20 May 2016). "Hanmi Pharmaceutical introduced first domestically developed lung cancer drug". The Korea Times .
  3. 1 2 "History". Hanmi Pharmaceutical. Retrieved 29 May 2019.
  4. 1 2 3 Keenan, Joseph (April 14, 2016). "South Korea's Hanmi to spend $200M in China expansion". FiercePharma.
  5. 1 2 Kim, Marie (4 July 2016). "Hanmi Pharmaceutical to Step Up R&D Investment to Further Develop Core Technologies". BusinessKorea.
  6. "Research programme: long-acting conjugate therapeutics - Hanmi Pharmaceutical". AdisInsight. Retrieved 25 March 2017.
  7. Garde, Damian (March 19, 2015). "Lilly inks a $690M deal to get its hands on an autoimmune drug". FierceBiotech.
  8. 1 2 Lane, EJ (November 10, 2015). "Janssen the latest Big Pharma to join Hanmi's South Korea deal machine". FiercePharma.
  9. "Sanofi, Hanmi Ink Up-to-$4.2B Long-Acting Diabetes Drug Alliance". GEN -- Genetic Engineering & Biotechnology News. November 5, 2015.
  10. Terry, Mark (September 30, 2016). "Deaths Lead Boehringer Ingelheim to Cancel 730 Million Cancer Deal With Hanmi Pharma Hanmi Stock Tanks". Biospace.
  11. Taylor, Phil (September 30, 2016). "UPDATED: After patient fatality, Hanmi loses Boehringer, gains Roche in $800M-plus cancer-partner shuffle". FiercePharma.
  12. Chan-ok, Shin (29 December 2016). "Hanmi Pharm downsizes license deal with Sanofi over diabetes drugs". Pulse News (in Korean).
  13. Bitting, Angela (3 December 2019). "RAPT THERAPEUTICS AND HANMI PHARMACEUTICAL ANNOUNCE COLLABORATION TO DEVELOP AND COMMERCIALIZE FLX475 IN ASIA". Rapt Therapeutics.
  14. "Hanmi Pharmaceutical chairman dies at 80". The Korea Times . 2020-08-03. Retrieved 2020-08-04.
  15. "Hanmi Pharm's US partner for anticancer drug files for bankruptcy". Korea Biomedical Review . May 16, 2023. Retrieved May 16, 2023.
  16. Taylor, Phil (October 7, 2016). "Smarting from failed Boehringer deal, Hanmi faces more pain from insider trading probe". FiercePharma.
  17. Mi-jung, Bae; Tae-yang, Yoo (December 2, 2012). "Hanmi Pharm employees charged over insider trading". Pulse by Maeil Business News Korea (in Korean).
  18. Ji-young, Sohn (14 December 2016). "Prosecution charges 17 over Hanmi Pharmaceutical disclosure case". The Korea Herald .
  19. Carroll, John (October 1, 2016). "Following lethal tox report, Boehringer scraps plans for high-speed development, kills $730M Hanmi deal". Endpoints.
  20. Adams, Ben (April 17, 2017). "Hanmi hit over failure to disclose olmutinib cancer trial side effect". FierceBiotech.
  21. "Zai Lab returns China rights for olmutinib to Hanmi". BioWorld. April 11, 2018.
  22. Taylor, Phil (April 13, 2018). "Hanmi calls time on troubled Tagrisso rival olmutinib". FierceBiotech.